Search results
Johnson & Johnson to acquire Proteologix for $850 million
Reuters via Yahoo Finance· 5 days agoProteologix's antibody PX128 is ready to enter early-stage development for moderate to severe atopic...
Johnson & Johnson to acquire Proteologix for $850 million
New Hampshire Union Leader· 5 days agoJohnson & Johnson said it would acquire Proteologix for $850 million as it looks to gain access to...
‘Am I OK?’ Trailer: Dakota Johnson Discovers She’s a Lesbian in Friendship Dramedy
indieWIRE· 14 hours agoDakota Johnson stars in 'Am I OK?'
Johnson & Johnson To Acquire Early-Stage Eczema Treatment Developer Proteologix For $850M
Benzinga· 5 days agoThursday, Johnson & Johnson JNJ agreed to acquire Proteologix Inc., a privately held biotechnology...
Johnson & Johnson (NYSE:JNJ) Stock Holdings Decreased by Gateway Advisory LLC
ETF DAILY NEWS· 7 days agoGateway Advisory LLC reduced its position in Johnson & Johnson (NYSE:JNJ – Free Report) by 66.0% in the 4th quarter, according to the company in its most ...
Study shows Illinois among the highest for massive jury verdicts against companies
The Center Square· 10 hours agoJust this month, Johnson & Johnson and Kenvue were ordered by an Illinois court to pay $45 million...
Nancy Johnson - The Morning Sun
The Morning Sun· 3 hours agoNancy L. Johnson, 77, of Pittsburg, passed away at 5:44 a.m. Saturday, May 18, 2024, at Freeman West Hospital in Joplin, Missouri.
A Springtime for Pseudo-Legislation
The Dispatch via Yahoo News· 1 hour agoSpeaker Mike Johnson and Majority Whip Tom Emmer talk to reporters following their weekly GOP caucus meeting at the U.S. Capitol Visitors Center on...
Johnson & Johnson to acquire Proteologix for $850 million By Reuters
Investing.com· 5 days agoProteologix's antibody PX128 is ready to enter early-stage development for moderate to severe atopic...
J&J posts latest Varipulse data while awaiting FDA review
MedTech Dive via Yahoo Finance· 22 hours agoDive Brief: Johnson & Johnson published data on Friday showing that 75% of patients were free from...
